22 results
6-K
EX-99.3
ENLV
Enlivex Therapeutics Ltd
27 Mar 19
Securities Purchase Agreement
8:32am
are the responsibility of the company’s management.
We conducted our reviews in accordance with the standards of the Public Company Accounting Oversight Board … Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
2 Aug 21
Enlivex Hires Biotech Industry Veteran Tzvi Palash to Lead the Design and Construction of its New cGMP Allocetra Manufacturing Plant
8:02am
, construction, scale-up and regulatory oversight of an Israel-based manufacturing facility as a COO and General Manager at ColBar LifeScience Ltd
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
support and oversight of patient eligibility. Dr. François was the national coordinator for numerous emergency trials, especially in sepsis, and has
6-K
EX-99.4
ENLV
Enlivex Therapeutics Ltd
27 Mar 19
Securities Purchase Agreement
8:32am
Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal
F-1/A
j5etpcoeqwo qe
8 Jul 14
Registration statement (foreign) (amended)
12:00am
424B4
1oa7d64z 2pmzsu
31 Jul 14
Prospectus supplement with pricing info
12:00am
20-F
98k04z4 b8dxp7h
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
edpwqiy5e
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
nfpt4ew spmp
29 Mar 24
Report of Foreign Private Issuer
4:30pm
20-F/A
agb1xd 53
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-10.1
1sd0soluhuaik h8
30 Dec 22
Report of Foreign Private Issuer
4:02pm